Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-07-18
2006-07-18
Jiang, Shaojia A. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S055000, C514S056000, C514S057000, C514S059000, C514S934000
Reexamination Certificate
active
07078392
ABSTRACT:
A method for treating and preventing various infections, including papilloma virus and fungal and parasitic infections is provided. In particular, an effective amount of a sulfated polysaccharide, such as cellulose sulfate and dextran sulfate are administered to prevent and treat these infections. The invention also relates to use of these compounds for the prevention and inhibition of malignant epithelial lesions associated with papilloma virus, such as cervical cancer.
REFERENCES:
patent: 4840941 (1989-06-01), Ueno et al.
patent: 5208031 (1993-05-01), Kelly
patent: 5288704 (1994-02-01), Ungheri et al.
patent: 5853767 (1998-12-01), Melman
patent: 5958461 (1999-09-01), Larsen
patent: 6063773 (2000-05-01), Anderson et al.
patent: 6239182 (2001-05-01), Zaneveld et al.
patent: 0 116 251 (1983-12-01), None
patent: 0 298 706 (1988-07-01), None
patent: 402078 (1990-12-01), None
patent: 0 497 341 (1992-08-01), None
patent: 0 676 206 (1995-10-01), None
patent: 411080003 (1999-03-01), None
patent: WO 94 08574 (1994-04-01), None
Christensen, N.D., et al.,Papillomavirus microbial activities of high-molecular-weight cellulose sulfate, dextran sulfate and polystyrene sulfonate. Antimicrobial Agents and Chemotherapy, Dec. 2001, 45:3427-3432.
Anderson, R.A., et al.,Preclinical Evaluation of Sodium Cellulose Sulfate(Ushercell)as a Contraceptive Antimicrobial Agent. Journal of Andrology, Jun. 2002, 23:426-438.
Simoes, et al.,Two Novel Vaginal Microbicides(Polystyrene Sulfonate and Cellulose Sulfate)Inhibit Gardnerella vaginalis and Anaerobes Commonly Associated with Bacterial Vaginosis. Antimicrobial Agents and Chemotherapy, Aug. 2002, vol. 46, No. 8, p. 2692-2695.
Joyce, et al.The L1 Major Capsid Protein of Human Papillomavirus Type 11 Recombinant Virus-like Particles Interacts with Heparin and Cell-surface Glycosaminoglycans on Human Keratinocytes. The Journal of Biological Chemisty, 1999, vol. 274, No. 9, Feb. 26, pp. 5810-5822.
Hermonat, et al.The spermicide nonoxynol-9 does not inactivate papillomavirusSex. Transm. Dis. 1992; 19:203-205.
Tzenan Giroglou, et al.Human Papillomavirus Infection Requires Cell Surface Heparan SulfateJournal of Virology, Feb. 2001, p. 1565-1570.
Pisani, P., et al.Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. International Journal of Cancer 55:891-903. 1993.
Christensen, N. D., et al. 1995.Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies. Virology 207:136-142.
Christensen, N. D., et al.1990. Monoclonal antibody-mediated neutralization of infectious human papillomavirus type11. J. Virol. 64:5678-5681.
Sokal, D. C., et al. 1995.Inactivation of papillomavirus by low concentrations of povidone-iodine. Sex Transm.Dis. 22:22-24.
Howett, M. K., et al. 1999.A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses. Antimicrob. Agents Chemother. 43:314-321.
Howett, M. K., et al.Alkyl sulfates: a new family of broad spectrum microbicides. XIII International AIDS Conference, 707-712. 2000. Durban, South Africa, Monduzzi Editore.
Yamamoto et al.,Carbohydrate Polymers14 (1990) 53-63.
Dvoretzky, I., et al. 1980.A quantitative in vitro focus assay for bovine papilloma virus. Virology 103:369-375.
Smith, L. H., et al. 1993.In vitro HPV-11 infection of human foreskin. J.Invest.Dermatol. 101:292-295.
Ludmerer, S. W., et al. 2000.HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain. Virology 266:237-245.
Smith, L. H., et al. 1995.Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro. J.Invest.Dermatol. 105:438-444.
Saggau, D. D. et al. “Replication of Fungi in K-Sol Corneal Preservation Medium at 4° C.”. Archives of Ophthalmology, vol. 104, Sep. 1986, 1362-1363.
Klotz, S. A. et al. “Glycosaminoglycans inhibit Cadida albican adherence to extracellular matrix proteins”. FEMS Microbiology Letters, (1992), 205-208.
Anderson Robert A.
Usher Thomas C.
Zaneveld Lourens J. D.
Eckert Seamans Cherin & Mellot LLC
Jiang Shaojia A.
Polydex Pharmaceuticals Limited
Rush-Presbyterian-St. Luke's Medical Center
Silverman Arnold B.
LandOfFree
Cellulose sulfate and other sulfated polysaccharides to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cellulose sulfate and other sulfated polysaccharides to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cellulose sulfate and other sulfated polysaccharides to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3568288